RAC 2.92% $1.94 race oncology ltd

RAC - Charts & Price Action, page-18469

  1. 8,405 Posts.
    lightbulb Created with Sketch. 1383
    Are you aware that bisantrene was approved as a cancer treatment by the French regulator in 1990?
    Or maybe you are aware of that, but you think that the regulator made a mistake?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.